Eiger BioPharmaceuticals

$9.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.50 (+5.71%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell EIGR and other stocks, options, and ETFs commission-free!

About EIGR

Eiger BioPharmaceuticals, Inc. Common Stock, also called Eiger BioPharmaceuticals, is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA. The listed name for EIGR is Eiger BioPharmaceuticals, Inc. Common Stock.

CEO
David A. Cory
Employees
24
Headquarters
Palo Alto, California
Founded
2008
Market Cap
300.92M
Price-Earnings Ratio
Dividend Yield
Average Volume
719.89K
High Today
$9.37
Low Today
$8.70
Open Price
$8.76
Volume
537.35K
52 Week High
$15.82
52 Week Low
$4.55

Collections

EIGR Earnings

-$0.95
-$0.63
-$0.32
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 12, After Hours

You May Also Like